IntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson's Disease
– Manufacturing of both active and placebo films underway for planned 18-month study –
Stay updated with breaking news from Dwight Gorham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Manufacturing of both active and placebo films underway for planned 18-month study –
Operator: Greetings and welcome to the IntelGenx First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen-only mode.
SAINT LAURENT, Quebec, May 11, 2023 -- IntelGenx Technologies Corp. today reported financial results for the first quarter ended March 31, 2023. All dollar amounts are expressed in... | May 11, 2023
SAINT LAURENT, Quebec, April 13, 2023 -- IntelGenx Technologies Corp. today announced various changes to its management team. Following the planned retirement of its founder and CEO, Horst... | April 13, 2023